|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
S. Africa Awards $667 Million HIV Drugs Supply Contract to Abbott Laboratories (ABT), Adcock Ingram, and 10 Other Firms
11/29/2012 7:25:57 AM
South Africa on Thursday awarded a $667 million contract to supply life-prolonging HIV medicine to 12 international and domestic firms, to deal with its biggest health problem. Companies that include Aspen Pharmacare, Abbott Laboratories and Adcock Ingram would share the contract, the health department said. The 5.9 billion rand ($667 million) contract, effective from April next year, aims to increase the number of people on treatment by nearly 50 percent, to 2.5 million next year. South Africa has nearly 6 million people infected with HIV -- one of the heaviest caseloads in the world. It also has one of largest treatment programmes. But drug makers are unlikely to rake in big profits from the government award, analysts have ssaid, given the stiff competition in the bidding. The health department said it saved 2.2 billion rand on the new contract, which it initially expected it would cost 8.1 billion rand.
|
|
|
|
|
|
|
|
|
|
|